The LOX metabolic pathway in AA metabolism activates the dysregulation of hepatic glucolipid metabolism, leading to the appearance of IR and NAFLD phenotypes. The gene discussed is LOX; the disease is metabolic dysfunction-associated steatotic liver disease.